Advertisement

Interleukin-6 as a diagnostic marker for infection in critically ill patients: A systematic review and meta-analysis

      Abstract

      Background

      The ability of blood levels of interleukin (IL)-6 to differentiate between infection and non-infection in critically ill patients with suspected infection is unclear. We assessed the diagnostic accuracy of serum IL-6 levels for the diagnosis of infection in critically ill patients.

      Methods

      We systematically searched the PubMed, MEDLINE, Cochrane Resister of Controlled Trials, Cochrane Database of Systematic Reviews, CINAHL, and Igaku Chuo Zasshi databases for studies published from 1986 to August 2016 that evaluated the accuracy of IL-6 levels for the diagnosis of infection. We constructed 2 × 2 tables and calculated summary estimates of sensitivity and specificity using a bivariate random-effects model.

      Results

      The literature search identified 775 articles, six of which with a total of 527 patients were included according to the predefined criteria. The pooled sensitivity, specificity, and diagnostic odds ratio were 0.73 (95% confidence interval [CI], 0.61–0.82), 0.76 (95% CI, 0.61–0.87), and 2.31 (95% CI, 1.20–3.48), respectively. The area under the curve (AUC) of the summary receiver operator characteristic (SROC) curve was 0.81 (95% CI, 0.78–0.85). In the secondary analysis of two studies with a total of 263 adult critically ill patients with organ dysfunction, the pooled sensitivity, specificity, and diagnostic odds ratio were 0.81 (95% CI, 0.75–0.86), 0.77 (95% CI, 0.67–0.84), and 2.87 (95% CI 2.15–3.60), respectively.

      Conclusions

      Blood levels of IL-6 have a moderate diagnostic value and a potential clinical utility to differentiate infection in critically ill patients with suspected infection.

      Keywords

      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Singer M.
        • Deutschman C.S.
        • Seymour C.W.
        • Shankar-Hari M.
        • Annane D.
        • Bauer M.
        • et al.
        The third international consensus definitions for sepsis and septic shock (Sepsis-3).
        JAMA. 2016; 315: 801-810
        • Rhodes A.
        • Evans L.E.
        • Alhazzani W.
        • Levy M.M.
        • Antonelli M.
        • Ferrer R.
        • et al.
        Surviving sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016.
        Crit Care Med. 2017; 45: 486-552
        • Lever A.
        • Mackenzie I.
        Sepsis: definition, epidemiology, and diagnosis.
        BMJ. 2007; 335: 879-883
        • Vincent J.L.
        • Opal S.M.
        • Marshall J.C.
        • Tracey K.J.
        Sepsis definitions: time for change.
        Lancet. 2013; 381: 774-775
        • Pierrakos C.
        • Vincent J.L.
        Sepsis biomarkers: a review.
        Crit Care. 2010; 14: R15
        • Simon L.
        • Gauvin F.
        • Amre D.K.
        • Saint-Louis P.
        • Lacroix J.
        Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.
        Clin Infect Dis. 2004; 39: 206-217
        • Oda S.
        • Hirasawa H.
        • Shiga H.
        • Nakanishi K.
        • Matsuda K.
        • Nakamua M.
        Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis.
        Cytokine. 2005; 29: 169-175
        • Wacker C.
        • Prkno A.
        • Brunkhorst F.M.
        • Schlattmann P.
        Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis.
        Lancet Infect Dis. 2013; 13: 426-435
        • Zheng Z.
        • Jiang L.
        • Ye L.
        • Gao Y.
        • Tang L.
        • Zhang M.
        The accuracy of presepsin for the diagnosis of sepsis from SIRS: a systematic review and meta-analysis.
        Ann Intensive Care. 2015; 5: 48
        • Takahashi W.
        • Nakada T.A.
        • Yazaki M.
        • Oda S.
        Interleukin-6 levels act as a diagnostic marker for infection and a prognostic marker in patients with organ dysfunction in intensive care units.
        Shock. 2016; 46 (Augusta, Ga): 254-260
        • Zhang X.
        • Liu D.
        • Liu Y.N.
        • Wang R.
        • Xie L.X.
        The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis.
        Crit Care. 2015; 19: 323
        • Wu J.
        • Hu L.
        • Zhang G.
        • Wu F.
        • He T.
        Accuracy of Presepsin in sepsis diagnosis: a systematic review and meta-analysis.
        PLoS One. 2015; 10e0133057
        • Tang B.M.
        • Eslick G.D.
        • Craig J.C.
        • Mclean A.S.
        Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.
        Lancet Infect Dis. 2007; 7: 210-217
        • Bone R.C.
        • Balk R.A.
        • Cerra F.B.
        • Dellinger R.P.
        • Fein A.M.
        • Knaus W.A.
        • et al.
        Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine.
        Chest. 1992; 101: 1644-1655
        • Calandra T.
        • Cohen J.
        The international sepsis forum consensus conference on definitions of infection in the intensive care unit.
        Crit Care Med. 2005; 33: 1538-1548
        • Horan T.C.
        • Andrus M.
        • Dudeck M.A.
        CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.
        Am J Infect Control. 2008; 36: 309-332
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        PLoS Med. 2009; 6e1000097
        • Whiting P.F.
        • Rutjes A.W.
        • Westwood M.E.
        • Mallett S.
        • Deeks J.J.
        • Reitsma J.B.
        • et al.
        QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.
        Ann Intern Med. 2011; 155: 529-536
        • Leeflang M.M.
        • Deeks J.J.
        • Gatsonis C.
        • Bossuyt P.M.
        Systematic reviews of diagnostic test accuracy.
        Ann Intern Med. 2008; 149: 889-897
        • Fassbender K.
        • Pargger H.
        • Muller W.
        • Zimmerli W.
        Interleukin-6 and acute-phase protein concentrations in surgical intensive care unit patients: diagnostic signs in nosocomial infection.
        Crit Care Med. 1993; 21: 1175-1180
        • Harbarth S.
        • Holeckova K.
        • Froidevaux C.
        • Pittet D.
        • Ricou B.
        • Grau G.E.
        • et al.
        Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.
        Am J Respir Crit Care Med. 2001; 164: 396-402
        • Du B.
        • Pan J.
        • Chen D.
        • Li Y.
        Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin.
        Chin Med J (Engl). 2003; 116: 538-542
        • Ramirez P.
        • Ferrer M.
        • Gimeno R.
        • Tormo S.
        • Valencia M.
        • Piner R.
        • et al.
        Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study.
        Crit Care Med. 2009; 37: 1691-1695
        • Li L.
        • Zhu Z.
        • Chen J.
        • Ouyang B.
        • Chen M.
        • Guan X.
        Diagnostic value of soluble triggering receptor expressed on myeloid cells-1 in critically-ill, postoperative patients with suspected sepsis.
        Am J Med Sci. 2013; 345: 178-184
        • Hou T.
        • Huang D.
        • Zeng R.
        • Ye Z.
        • Zhang Y.
        Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis.
        Int J Clin Exp Med. 2015; 8: 15238-15245
        • Ma L.
        • Zhang H.
        • Yin Y.L.
        • Guo W.Z.
        • Ma Y.Q.
        • Wang Y.B.
        • et al.
        Role of interleukin-6 to differentiate sepsis from non-infectious systemic inflammatory response syndrome.
        Cytokine. 2016; 88: 126-135
        • Liu Y.
        • Hou J.H.
        • Li Q.
        • Chen K.J.
        • Wang S.N.
        • Wang J.M.
        Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis.
        Springerplus. 2016; 5: 2091
        • Nakamura Y.
        • Ishikura H.
        • Nishida T.
        • Kawano Y.
        • Yuge R.
        • Ichiki R.
        • et al.
        Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury.
        BMC Anesthesiol. 2014; 14: 88
        • Heredia-Rodriguez M.
        • Bustamante-Munguira J.
        • Fierro I.
        • Lorenzo M.
        • Jorge-Monjas P.
        • Gomez-Sanchez E.
        • et al.
        Procalcitonin cannot be used as a biomarker of infection in heart surgery patients with acute kidney injury.
        J Crit Care. 2016; 33: 233-239
        • Takahashi W.
        • Nakada T.A.
        • Abe R.
        • Tanaka K.
        • Matsumura Y.
        • Oda S.
        Usefulness of interleukin 6 levels in the cerebrospinal fluid for the diagnosis of bacterial meningitis.
        J Crit Care. 2014; 29 (693.e1-6)
        • Gomez H.G.
        • Gonzalez S.M.
        • Londono J.M.
        • Hoyos N.A.
        • Nino C.D.
        • Leon A.L.
        • et al.
        Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study*.
        Crit Care Med. 2014; 42: 771-780